Mathaiyan Jayanthi
Overview
Explore the profile of Mathaiyan Jayanthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bage I, Kamalanathan S, Selvarajan S, Sahoo J, Jayanthi M, Naik D
Cureus
. 2023 Oct;
15(9):e45985.
PMID: 37900537
Background: Dyslipidemia is an important comorbid factor of type 2 diabetes mellitus (T2DM) that increases the risk of cardiovascular diseases. This study aimed to assess the pattern of dyslipidemia and...
2.
Gauthaman J, Jayanthi M
Cureus
. 2022 Mar;
14(1):e21755.
PMID: 35251826
Introduction With high prevalence rates across the population, dental pain is the most common symptom that drives a patient to visit the dentist. Dentists prescribe analgesics and antibiotic prophylaxis apart...
3.
Meena D, Jayanthi M, Ramasamy K, Thulasingam M
Cureus
. 2022 Feb;
14(1):e21389.
PMID: 35198298
Background Large amounts of medicines are wasted during procurement, storage, distribution, and utilization. Proper procurement, storage, dispensing, and documentation of medicines are important aspects of pharmacy management. The World Health...
4.
Meena D, Jayanthi M, Ramasamy K, T M
Cureus
. 2021 Dec;
13(11):e19419.
PMID: 34926013
Introduction The supply of essential medicines is one of the vital components of primary health care. One of the important objectives of Indian health policy is to provide all the...
5.
Meena D, Jayanthi M
Cureus
. 2021 Nov;
13(10):e18431.
PMID: 34737900
Introduction Antimicrobial resistance is a serious problem to solve for the public health authorities at the global level, particularly in developing countries like India. One of the possible reasons for...
6.
Meena D, Jayanthi M
Indian J Community Med
. 2021 May;
46(1):93-96.
PMID: 34035585
Background: About 60%-90% of healthcare spending in India is on medicine which is mainly out of pocket. Almost all the drugs including antibiotics are available as brands with variable cost....
7.
Varma A, Jayanthi M, Dubashi B, Shewade D, Sundaram R
Drug Metab Pers Ther
. 2020 Sep;
35(4).
PMID: 32966231
Objectives: High interindividual variability was reported with capecitabine toxicities among colorectal cancer (CRC) patients. polymorphism was reported responsible for grade 3 or 4 toxicities. Finding the phenotypic association between polymorphism...
8.
Holloway K, Ivanovska V, Manikandan S, Jayanthi M, Mohan A, Forte G, et al.
PLoS One
. 2020 Feb;
15(2):e0228201.
PMID: 32027679
Background: Poor quality use of medicines (QUM) has adverse outcomes. Governments' implementation of essential medicines (EM) policies is often suboptimal and there is limited information on which policies are most...
9.
Avishek A, Jayanthi M, Biswajit D
Eur J Clin Pharmacol
. 2017 Jul;
73(11):1519-1521.
PMID: 28752256
No abstract available.